IMV 

$0.000010
24
-$0.00-99.5%Wednesday 14:58

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.002
52W Low
0.00001
Volume
358
Avg. Volume
94
Mkt Cap
83.43
P/E Ratio
-
Dividend Yield
2,523,277.23%
Dividend
0.25

Upcoming

Dividends

2,523,277.23%Dividend Yield
Dec 2026
$0.25
Dec 2025
$0.19
Dec 2024
$0.13
Dec 2023
$0.08
Dec 2022
$0.08
10Y Growth
16.53%
5Y Growth
28.69%
3Y Growth
44.22%
1Y Growth
50%

Earnings

Feb 5Expected
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
5.01
22.73
40.45
58.17
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
0Revenue
-37.99MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap90.38B
Moderna, Inc. is a competitor because it also focuses on mRNA technology for developing vaccines and therapeutics, similar to IMV's delivery platform for immunotherapies.
BioNTech
BNTX
Mkt Cap21.22B
BioNTech SE operates in the same space as IMV, developing and commercializing immunotherapies for cancer and other serious diseases, including mRNA-based vaccines.
Novavax
NVAX
Mkt Cap1.41B
Novavax, Inc. competes with IMV in the development of vaccines for infectious diseases, using its nanoparticle vaccine technology.
Pfizer
PFE
Mkt Cap164.67B
Pfizer Inc. is a broad-based competitor, involved in the development of vaccines and therapeutics, including its partnership with BioNTech on a COVID-19 vaccine, competing with IMV's infectious disease focus.
Johnson & Johnson
JNJ
Mkt Cap687.89B
Johnson & Johnson is involved in the research and development of vaccines and therapeutics for infectious diseases, making it a competitor in the same market as IMV.
Gilead Sciences
GILD
Mkt Cap208.48B
Gilead Sciences, Inc. competes with IMV in the development of therapeutics for infectious diseases and cancer, with a focus on antiviral drugs.
AMGEN
AMGN
Mkt Cap251.89B
Amgen Inc. competes in the biotechnology space, focusing on innovative therapeutics, including immunotherapies, which puts it in competition with IMV.
Regeneron Pharmaceuticals
REGN
Mkt Cap98.84B
Regeneron Pharmaceuticals, Inc. is known for its development of monoclonal antibodies for the treatment of cancer and infectious diseases, competing with IMV's focus areas.
Novartis
NVS
Mkt Cap303.12B
Novartis AG competes with IMV in the development of novel healthcare solutions, including vaccines and cancer therapies, through its extensive research and development efforts.
Astrazeneca
AZN
Mkt Cap286.07B
AstraZeneca PLC competes in the development of vaccines and therapeutics for infectious diseases and cancer, overlapping with IMV's research and development focus.

About

IMV Corporation specializes in the global production and distribution of advanced systems for simulating and measuring vibrations, serving markets both in Japan and internationally. Its comprehensive product line features electrodynamic vibration testing apparatus, diverse measurement tools, vibration control units, amplifier upgrade solutions, seismographs, vibration detection sensors, and reliability assessment platforms. The company is also actively involved in the design, fabrication, servicing, and upkeep of both vibration and environmental test systems. Complementing its hardware, IMV provides specialized services such as dedicated laboratory testing, detailed measurement analysis, and expert consultancy for vibration-related assessments. Furthermore, the company offers leasing options for its vibration test machinery. Established in 1957, IMV Corporation maintains its primary operational headquarters in Osaka, Japan.
Show More
CEO
Jumpei Kojima
Employees
373
Country
Canada
ISIN
CA44974L3011

Listings

0 Comments

Share your thoughts

FAQs

What is IMV stock price today?▼
The current price of IMVIF is $0.00 USD — it has decreased by -99.5% in the past 24 hours. Watch IMV stock price performance more closely on the chart.
What is IMV stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange IMV stocks are traded under the ticker IMVIF.
Is IMV stock price growing?▼
IMVIF stock has fallen by -99.5% compared to the previous week, the month change is a -99.5% fall, over the last year IMV has showed a -90% decrease.
What is IMV market cap?▼
Today IMV has the market capitalization of 83.43
When is the next IMV earnings date?▼
IMV is going to release the next earnings report on February 5, 2027.
What were IMV earnings last quarter?▼
IMVIF earnings for the last quarter are 0.24 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is IMV revenue for the last year?▼
IMV revenue for the last year amounts to 0 USD.
What is IMV net income for the last year?▼
IMVIF net income for the last year is -37.99M USD.
How many employees does IMV have?▼
As of November 22, 2026, the company has 373 employees.
In which sector is IMV located?▼
IMV operates in the Technology sector.
When did IMV complete a stock split?▼
The last stock split for IMV was on May 10, 2018 with a ratio of 1:3.2.
Where is IMV headquartered?▼
IMV is headquartered in Osaka, Canada.